Methods of hemodialysis utilizing grafts coated with cells expressing human fibulin-5
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Feb 15, 2011
Grant Date -
Aug 16, 2007
app pub date -
Jan 3, 2007
filing date -
Jul 20, 2000
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The present relates to artificial vascular grafts and for methods for performing hemodialysis with the same. The grafts comprise an inner surface on which cells genetically altered to express or over-express one or more cell adhesion factors, such as fibulin-5, or one or more cell adhesion factors and one or more cell proliferation growth factors, such as VEGF, are seeded and cultured.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully